D
Dyne Therapeutics, Inc. DYN
$10.05 $0.202.03% NASDAQ
Recommendation
Prev Close
Volume
Avg Vol (90D)
Market Cap
Dividend & Yield
--
52-Week Range
P/E (TTM)
--
EPS (TTM)

06/30/2025 03/31/2025 12/31/2024 09/30/2024 06/30/2024
Net Income -70.28% -75.72% -34.37% -61.31% -0.31%
Total Depreciation and Amortization 26.07% 30.05% 12.78% 1.62% -7.42%
Total Amortization of Deferred Charges -- -- -- -- --
Total Other Non-Cash Items 79.02% -35.73% 72.55% 68.46% 20.78%
Change in Net Operating Assets 32.95% 89.03% -119.92% 215.09% 1.05%
Cash from Operations -72.60% -34.83% -140.92% -47.48% 1.39%
Capital Expenditure 93.00% -413.61% -1,210.98% -51.50% -242.80%
Sale of Property, Plant, and Equipment -- -- -- -- --
Cash Acquisitions -- -- -- -- --
Divestitures -- -- -- -- --
Other Investing Activities -43.20% 101.36% -156.83% -247.44% -31.18%
Cash from Investing -39.38% 100.81% -161.12% -251.34% -35.16%
Total Debt Issued -- -- -- -- --
Total Debt Repaid -- -- -- -- --
Issuance of Common Stock -99.48% -65.41% 2,373.47% 3,866.74% 1,425.18%
Repurchase of Common Stock -- -- -- -- --
Issuance of Preferred Stock -- -- -- -- --
Repurchase of Preferred Stock -- -- -- -- --
Total Dividends Paid -- -- -- -- --
Other Financing Activities -- -- -- -- --
Cash from Financing -73.47% -65.41% 2,373.47% 3,866.74% 1,425.18%
Foreign Exchange rate Adjustments -- -- -- -- --
Miscellaneous Cash Flow Adjustments -- -- -- -- --
Net Change in Cash -96.18% -75.46% -1,016.35% -103.67% 2,589.40%